QuadMedicine

QuadMedicine FCF per Share

The Free Cash Flow per Share of QuadMedicine (464490.KQ) as of Oct 30, 2026 is -214.51 KRW. In the previous year, Free Cash Flow per Share was -895.07 KRW — a change of -76.03% (higher).

FCF per Share

-214.51KRW

YoY

-76.03%

Last updated:

Free Cash Flow per Share of QuadMedicine is 2024 -214.51 KRW. Free Cash Flow per Share of QuadMedicine was 2023 -895.07 KRW. It decreases by -76.03% higher compared to the previous year.

The QuadMedicine FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2023
-895.07 KRW
Jan 1, 2024
-214.51 KRW
The QuadMedicine FCF per Share history
YEARFCF per ShareYoY
-214.51KRW-76.03%
-895.07KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

QuadMedicine Stock analysis

What does QuadMedicine do? QuadMedicine Inc operates through two segments: the Pharmaceutical segment, which develops synthetic drugs and vaccine products via the CDMO model, and the Other segment, which provides research services. The company generates revenue by offering contract development and manufacturing services for pharmaceutical products and research services to clients in the pharmaceutical industry. Clients include pharmaceutical companies seeking to outsource drug development and manufacturing, as well as organizations requiring specialized research support. The Pharmaceutical segment focuses on microneedle-based drug delivery systems, leveraging the company's R&D capabilities to create innovative solutions for drug administration. The Other segment supports clients with research services, likely targeting institutions and firms needing external expertise in pharmaceutical research. Revenue streams are directly tied to these service offerings, with no mention of product sales or other revenue sources beyond the described segments. QuadMedicine is one of the most popular companies on Eulerpool.

Frequently Asked Questions about QuadMedicine stock

Free Cash Flow per Share of QuadMedicine is -214.51 KRW in 2024.

Free Cash Flow per Share of QuadMedicine changed from -895.07 KRW to -214.51 KRW, representing a -76.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share QuadMedicine since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — QuadMedicine

All Key Metrics — QuadMedicine